Literature DB >> 10611973

Mechanisms of viral interference with MHC class I antigen processing and presentation.

J W Yewdell1, J R Bennink.   

Abstract

Viruses are ubiquitous and dangerous obligate intracellular parasites. To facilitate recognition of virus-infected cells by the immune system, vertebrates evolved a system that displays oligopeptides derived from viral proteins on the surface of cells in association with class I molecules of the major histocompatibility complex. Here we review the mechanisms counter-evolved by viruses to interfere with the generation of viral peptides, their intracellular trafficking, or the cell surface expression of class I molecules bearing viral peptides. This topic is important in its own right because the viruses that encode these proteins represent medically important pathogens, are potential vectors for vaccines or gene therapy, and provide strategies and tools for blocking immune recognition in transplantation, autoimmunity, and gene therapy. In addition, studies on viral interference provide unique insights into unfettered antigen processing and normal cellular functions that are exploited and exaggerated by viruses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10611973      PMCID: PMC4781472          DOI: 10.1146/annurev.cellbio.15.1.579

Source DB:  PubMed          Journal:  Annu Rev Cell Dev Biol        ISSN: 1081-0706            Impact factor:   13.827


  26 in total

1.  A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation.

Authors:  L Coscoy; D Ganem
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

2.  Viruses in control of the immune system. Workshop on molecular mechanisms of immune modulation: lessons from viruses.

Authors:  Antonio Alcami; Peter Ghazal; Jonathan W Yewdell
Journal:  EMBO Rep       Date:  2002-10       Impact factor: 8.807

3.  Modulation of transporter associated with antigen processing (TAP)-mediated peptide import into the endoplasmic reticulum by flavivirus infection.

Authors:  F Momburg; A Müllbacher; M Lobigs
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

Review 4.  Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections.

Authors:  Maurice R Hilleman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-05       Impact factor: 11.205

Review 5.  Stealth and cunning: hepatitis B and hepatitis C viruses.

Authors:  Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Protease cleavage sites in HIV-1 gp120 recognized by antigen processing enzymes are conserved and located at receptor binding sites.

Authors:  Bin Yu; Dora P A J Fonseca; Sara M O'Rourke; Phillip W Berman
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

7.  Herpes B virus, macacine herpesvirus 1, breaks simplex virus tradition via major histocompatibility complex class I expression in cells from human and macaque hosts.

Authors:  Mugdha Vasireddi; Julia Hilliard
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

Review 8.  ERAP1 in the pathogenesis of ankylosing spondylitis.

Authors:  Emma Reeves; Tim Elliott; Edward James; Christopher J Edwards
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

9.  Coxsackievirus B4 infection of human fetal thymus cells.

Authors:  Fabienne Brilot; Vincent Geenen; Didier Hober; Cheryl A Stoddart
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation.

Authors:  Sebastien Apcher; Chrysoula Daskalogianni; Benedicte Manoury; Robin Fåhraeus
Journal:  PLoS Pathog       Date:  2010-10-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.